loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Azelastine HCl

    Menu

    Azelastine HCl

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 8,534Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 20114 / DOSAGE - SPRAY, METERED;NASAL - 0.137MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AZELASTINE HYDROCHLORIDE(UNII: 0L591QR10I)
    (AZELASTINE - UNII:ZQI909440X)     		AZELASTINE HYDROCHLORIDE137ug

    Inactive Ingredients

    Ingredient Name
    A-S Medication Solutions
    Meda Pharmaceuticals
    Wallace Pharmaceuticals Inc.
    BENZALKONIUM CHLORIDE(F5UM2KM3W7)
    CITRIC ACID MONOHYDRATE(2968PHW8QP)  
    EDETATE DISODIUM(7FLD91C86K) 
    HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) 
    SODIUM CHLORIDE(451W47IQ8X)  
    SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR) 
    SODIUM PHOSPHATE, DIBASIC(GR686LBA74)  
    SORBITOL(506T60A25R) 
    SUCRALOSE(96K6UQ3ZD4) 
    WATER(059QF0KO0R)